Compare Abbott Laboratories (ABT) vs Caterpillar Inc (CAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Caterpillar Inc — how do they compare? Abbott Laboratories trades at $95.6 (market cap $166.94B), while Caterpillar Inc trades at $935.05 (market cap $433.01B). The key difference: Caterpillar Inc is far larger — about 2.6× Abbott Laboratories's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | CAT | |
|---|---|---|
Market Cap | $166.94B | $433.01B |
Sector | Health | Industrials |
52-Week High | $136.62 | $1.06K |
52-Week Low | $82.57 | $394.29 |
Enterprise Value | $193.69B | $472.01B |
Dividend Yield | 2.63% | 0.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Caterpillar (CAT) trades at $969.92, up 0.66% on the day and near its 52-week high, supported by strong earnings beats and bullish technical signals. The stock's valuation multiples are elevated with a P/E of 48.3 and P/S of 6.44, but robust profitability metrics like a 51.35% ROE and consistent dividend growth underscore fundamental strength. Recent news highlights CAT's exposure to AI-driven infrastructure demand, with the Power & Energy segment emerging as a key growth driver amid a record backlog.
Outlook remains positive given earnings momentum and analyst consensus, though high valuation and macroeconomic sensitivity pose risks. The stock offers growth from data center and infrastructure trends, but investors should weigh premium pricing against potential cyclical headwinds in industrial markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Caterpillar Inc
Caterpillar Inc. designs, manufactures, and markets construction, mining, and forestry machinery. The Company also manufactures engines and other related parts for its equipment, and offers financing and insurance. Caterpillar distributes its products through a worldwide organization of dealers.
Read more on CAT →
